Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score
Objective To determine cutoff values for defining remission, minimal disease activity, and parent and child acceptable symptom state in juvenile idiopathic arthritis (JIA) using the Juvenile Arthritis Disease Activity Score (JADAS). Methods For the selection of cutoff values, data from a clinical da...
Gespeichert in:
Veröffentlicht in: | Arthritis & rheumatology (Hoboken, N.J.) N.J.), 2012-07, Vol.64 (7), p.2366-2374 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2374 |
---|---|
container_issue | 7 |
container_start_page | 2366 |
container_title | Arthritis & rheumatology (Hoboken, N.J.) |
container_volume | 64 |
creator | Consolaro, Alessandro Bracciolini, Giulia Ruperto, Nicolino Pistorio, Angela Magni-Manzoni, Silvia Malattia, Clara Pederzoli, Silvia Davì, Sergio Martini, Alberto Ravelli, Angelo |
description | Objective
To determine cutoff values for defining remission, minimal disease activity, and parent and child acceptable symptom state in juvenile idiopathic arthritis (JIA) using the Juvenile Arthritis Disease Activity Score (JADAS).
Methods
For the selection of cutoff values, data from a clinical database including 609 children with JIA were used. Optimal cutoff values were determined against external criteria by calculating the 75th percentile of cumulative score distribution and through receiver operating characteristic curve analysis. External criteria included formal definitions of inactive disease and minimal disease activity, subjective rating of remission by physicians, parents, and children, and rating of acceptable symptom state by parents and children. The choice of cutoffs was made based on clinical and statistical grounds. Cross‐validation was performed using 4 JIA patient samples that included a total of 1,323 patients, and was based on assessment of construct, discriminant, and predictive validity.
Results
With all versions of the JADAS, the cutoff score for classifying a patient as having inactive disease was 1, whereas the cutoff for classification of minimal disease activity was 2 for oligoarticular JIA and 3.8 for polyarticular JIA. Cutoffs for physicians', parents', and children's subjective rating of remission ranged from 2 to 2.3. Cutoffs for acceptable symptom state ranged from 3.2 to 5.4 for parents and from 3 to 4.5 for children. Results of cross‐validation analyses strongly supported the selected cutoff values.
Conclusion
Cutoff values for classifying various disease states in JIA using the JADAS were developed. In cross‐validation analyses, they proved to have good construct and discriminant validity and ability to predict disease outcome. |
doi_str_mv | 10.1002/art.34373 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1022839874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3277941431</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4563-6bab83b757a1c7b6fb00545d8f6bed1bfcec2959c9d844d2a2168cb33104178b3</originalsourceid><addsrcrecordid>eNp1kd1u1DAQhS0EokvhghdAlhASSE3rnzhOuKtaKD8VSKVQxI1lOxPW28QJtrew78RDYtjtVgJxZY39nTPHMwg9pGSfEsIOdEj7vOSS30IzKlhTEMrpbTQjhJQFFw3dQfdiXOSSccHvoh3GGKesrmfo5xkMLkY3-j08OO8G3ePWRdARsLbJXbm02sPat7myMCVtesBxNUxpHHBMOgF2Hi-WV-BdfnGtGyed5s7iHGoeXHLxOT6GLlv7r9jmCwhOY5P9Wzx6nOZwo95K_omAox0D3Ed3Ot1HeLA5d9HHly_Oj14Vp-9PXh8dnha2FBUvKqNNzY0UUlMrTdUZQkQp2rqrDLTUdBYsa0Rjm7Yuy5ZpRqvaGs4pKamsDd9FT9e-Uxi_LSEmlWdkoe-1h3EZFSWM1bypZZnRx3-hi3EZfE6nqKCSUllVNFPP1pQNY4wBOjWFPOqwylbq9wpV_rr6s8LMPto4Ls0A7Za83lkGnmwAHa3uu6C9dfGGq6iURJDMHay573m2q_93VIdn59eti7XCxQQ_tgodLlUluRTq4t2J-nLxtv7w5vMndcx_AdzgxVM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1517117661</pqid></control><display><type>article</type><title>Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Consolaro, Alessandro ; Bracciolini, Giulia ; Ruperto, Nicolino ; Pistorio, Angela ; Magni-Manzoni, Silvia ; Malattia, Clara ; Pederzoli, Silvia ; Davì, Sergio ; Martini, Alberto ; Ravelli, Angelo</creator><creatorcontrib>Consolaro, Alessandro ; Bracciolini, Giulia ; Ruperto, Nicolino ; Pistorio, Angela ; Magni-Manzoni, Silvia ; Malattia, Clara ; Pederzoli, Silvia ; Davì, Sergio ; Martini, Alberto ; Ravelli, Angelo ; Paediatric Rheumatology International Trials Organization ; for the Paediatric Rheumatology International Trials Organization</creatorcontrib><description>Objective
To determine cutoff values for defining remission, minimal disease activity, and parent and child acceptable symptom state in juvenile idiopathic arthritis (JIA) using the Juvenile Arthritis Disease Activity Score (JADAS).
Methods
For the selection of cutoff values, data from a clinical database including 609 children with JIA were used. Optimal cutoff values were determined against external criteria by calculating the 75th percentile of cumulative score distribution and through receiver operating characteristic curve analysis. External criteria included formal definitions of inactive disease and minimal disease activity, subjective rating of remission by physicians, parents, and children, and rating of acceptable symptom state by parents and children. The choice of cutoffs was made based on clinical and statistical grounds. Cross‐validation was performed using 4 JIA patient samples that included a total of 1,323 patients, and was based on assessment of construct, discriminant, and predictive validity.
Results
With all versions of the JADAS, the cutoff score for classifying a patient as having inactive disease was 1, whereas the cutoff for classification of minimal disease activity was 2 for oligoarticular JIA and 3.8 for polyarticular JIA. Cutoffs for physicians', parents', and children's subjective rating of remission ranged from 2 to 2.3. Cutoffs for acceptable symptom state ranged from 3.2 to 5.4 for parents and from 3 to 4.5 for children. Results of cross‐validation analyses strongly supported the selected cutoff values.
Conclusion
Cutoff values for classifying various disease states in JIA using the JADAS were developed. In cross‐validation analyses, they proved to have good construct and discriminant validity and ability to predict disease outcome.</description><identifier>ISSN: 0004-3591</identifier><identifier>ISSN: 2326-5191</identifier><identifier>EISSN: 1529-0131</identifier><identifier>EISSN: 2326-5205</identifier><identifier>DOI: 10.1002/art.34373</identifier><identifier>PMID: 22231288</identifier><identifier>CODEN: ARHEAW</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Antirheumatic Agents - therapeutic use ; Arthritis ; Arthritis, Juvenile - diagnosis ; Arthritis, Juvenile - drug therapy ; Arthritis, Juvenile - pathology ; Biological and medical sciences ; Child ; Diseases of the osteoarticular system ; Female ; Humans ; Inflammatory joint diseases ; Joints - pathology ; Male ; Medical research ; Medical sciences ; Methotrexate - therapeutic use ; Parents & parenting ; Reproducibility of Results ; Sensitivity and Specificity ; Severity of Illness Index ; Surveys and Questionnaires ; Treatment Outcome</subject><ispartof>Arthritis & rheumatology (Hoboken, N.J.), 2012-07, Vol.64 (7), p.2366-2374</ispartof><rights>Copyright © 2012 by the American College of Rheumatology</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 by the American College of Rheumatology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4563-6bab83b757a1c7b6fb00545d8f6bed1bfcec2959c9d844d2a2168cb33104178b3</citedby><cites>FETCH-LOGICAL-c4563-6bab83b757a1c7b6fb00545d8f6bed1bfcec2959c9d844d2a2168cb33104178b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fart.34373$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fart.34373$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26177050$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22231288$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Consolaro, Alessandro</creatorcontrib><creatorcontrib>Bracciolini, Giulia</creatorcontrib><creatorcontrib>Ruperto, Nicolino</creatorcontrib><creatorcontrib>Pistorio, Angela</creatorcontrib><creatorcontrib>Magni-Manzoni, Silvia</creatorcontrib><creatorcontrib>Malattia, Clara</creatorcontrib><creatorcontrib>Pederzoli, Silvia</creatorcontrib><creatorcontrib>Davì, Sergio</creatorcontrib><creatorcontrib>Martini, Alberto</creatorcontrib><creatorcontrib>Ravelli, Angelo</creatorcontrib><creatorcontrib>Paediatric Rheumatology International Trials Organization</creatorcontrib><creatorcontrib>for the Paediatric Rheumatology International Trials Organization</creatorcontrib><title>Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score</title><title>Arthritis & rheumatology (Hoboken, N.J.)</title><addtitle>Arthritis & Rheumatism</addtitle><description>Objective
To determine cutoff values for defining remission, minimal disease activity, and parent and child acceptable symptom state in juvenile idiopathic arthritis (JIA) using the Juvenile Arthritis Disease Activity Score (JADAS).
Methods
For the selection of cutoff values, data from a clinical database including 609 children with JIA were used. Optimal cutoff values were determined against external criteria by calculating the 75th percentile of cumulative score distribution and through receiver operating characteristic curve analysis. External criteria included formal definitions of inactive disease and minimal disease activity, subjective rating of remission by physicians, parents, and children, and rating of acceptable symptom state by parents and children. The choice of cutoffs was made based on clinical and statistical grounds. Cross‐validation was performed using 4 JIA patient samples that included a total of 1,323 patients, and was based on assessment of construct, discriminant, and predictive validity.
Results
With all versions of the JADAS, the cutoff score for classifying a patient as having inactive disease was 1, whereas the cutoff for classification of minimal disease activity was 2 for oligoarticular JIA and 3.8 for polyarticular JIA. Cutoffs for physicians', parents', and children's subjective rating of remission ranged from 2 to 2.3. Cutoffs for acceptable symptom state ranged from 3.2 to 5.4 for parents and from 3 to 4.5 for children. Results of cross‐validation analyses strongly supported the selected cutoff values.
Conclusion
Cutoff values for classifying various disease states in JIA using the JADAS were developed. In cross‐validation analyses, they proved to have good construct and discriminant validity and ability to predict disease outcome.</description><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis</subject><subject>Arthritis, Juvenile - diagnosis</subject><subject>Arthritis, Juvenile - drug therapy</subject><subject>Arthritis, Juvenile - pathology</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Diseases of the osteoarticular system</subject><subject>Female</subject><subject>Humans</subject><subject>Inflammatory joint diseases</subject><subject>Joints - pathology</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Methotrexate - therapeutic use</subject><subject>Parents & parenting</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><subject>Severity of Illness Index</subject><subject>Surveys and Questionnaires</subject><subject>Treatment Outcome</subject><issn>0004-3591</issn><issn>2326-5191</issn><issn>1529-0131</issn><issn>2326-5205</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kd1u1DAQhS0EokvhghdAlhASSE3rnzhOuKtaKD8VSKVQxI1lOxPW28QJtrew78RDYtjtVgJxZY39nTPHMwg9pGSfEsIOdEj7vOSS30IzKlhTEMrpbTQjhJQFFw3dQfdiXOSSccHvoh3GGKesrmfo5xkMLkY3-j08OO8G3ePWRdARsLbJXbm02sPat7myMCVtesBxNUxpHHBMOgF2Hi-WV-BdfnGtGyed5s7iHGoeXHLxOT6GLlv7r9jmCwhOY5P9Wzx6nOZwo95K_omAox0D3Ed3Ot1HeLA5d9HHly_Oj14Vp-9PXh8dnha2FBUvKqNNzY0UUlMrTdUZQkQp2rqrDLTUdBYsa0Rjm7Yuy5ZpRqvaGs4pKamsDd9FT9e-Uxi_LSEmlWdkoe-1h3EZFSWM1bypZZnRx3-hi3EZfE6nqKCSUllVNFPP1pQNY4wBOjWFPOqwylbq9wpV_rr6s8LMPto4Ls0A7Za83lkGnmwAHa3uu6C9dfGGq6iURJDMHay573m2q_93VIdn59eti7XCxQQ_tgodLlUluRTq4t2J-nLxtv7w5vMndcx_AdzgxVM</recordid><startdate>201207</startdate><enddate>201207</enddate><creator>Consolaro, Alessandro</creator><creator>Bracciolini, Giulia</creator><creator>Ruperto, Nicolino</creator><creator>Pistorio, Angela</creator><creator>Magni-Manzoni, Silvia</creator><creator>Malattia, Clara</creator><creator>Pederzoli, Silvia</creator><creator>Davì, Sergio</creator><creator>Martini, Alberto</creator><creator>Ravelli, Angelo</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7TM</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201207</creationdate><title>Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score</title><author>Consolaro, Alessandro ; Bracciolini, Giulia ; Ruperto, Nicolino ; Pistorio, Angela ; Magni-Manzoni, Silvia ; Malattia, Clara ; Pederzoli, Silvia ; Davì, Sergio ; Martini, Alberto ; Ravelli, Angelo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4563-6bab83b757a1c7b6fb00545d8f6bed1bfcec2959c9d844d2a2168cb33104178b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis</topic><topic>Arthritis, Juvenile - diagnosis</topic><topic>Arthritis, Juvenile - drug therapy</topic><topic>Arthritis, Juvenile - pathology</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Diseases of the osteoarticular system</topic><topic>Female</topic><topic>Humans</topic><topic>Inflammatory joint diseases</topic><topic>Joints - pathology</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Methotrexate - therapeutic use</topic><topic>Parents & parenting</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><topic>Severity of Illness Index</topic><topic>Surveys and Questionnaires</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Consolaro, Alessandro</creatorcontrib><creatorcontrib>Bracciolini, Giulia</creatorcontrib><creatorcontrib>Ruperto, Nicolino</creatorcontrib><creatorcontrib>Pistorio, Angela</creatorcontrib><creatorcontrib>Magni-Manzoni, Silvia</creatorcontrib><creatorcontrib>Malattia, Clara</creatorcontrib><creatorcontrib>Pederzoli, Silvia</creatorcontrib><creatorcontrib>Davì, Sergio</creatorcontrib><creatorcontrib>Martini, Alberto</creatorcontrib><creatorcontrib>Ravelli, Angelo</creatorcontrib><creatorcontrib>Paediatric Rheumatology International Trials Organization</creatorcontrib><creatorcontrib>for the Paediatric Rheumatology International Trials Organization</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Arthritis & rheumatology (Hoboken, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Consolaro, Alessandro</au><au>Bracciolini, Giulia</au><au>Ruperto, Nicolino</au><au>Pistorio, Angela</au><au>Magni-Manzoni, Silvia</au><au>Malattia, Clara</au><au>Pederzoli, Silvia</au><au>Davì, Sergio</au><au>Martini, Alberto</au><au>Ravelli, Angelo</au><aucorp>Paediatric Rheumatology International Trials Organization</aucorp><aucorp>for the Paediatric Rheumatology International Trials Organization</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score</atitle><jtitle>Arthritis & rheumatology (Hoboken, N.J.)</jtitle><addtitle>Arthritis & Rheumatism</addtitle><date>2012-07</date><risdate>2012</risdate><volume>64</volume><issue>7</issue><spage>2366</spage><epage>2374</epage><pages>2366-2374</pages><issn>0004-3591</issn><issn>2326-5191</issn><eissn>1529-0131</eissn><eissn>2326-5205</eissn><coden>ARHEAW</coden><abstract>Objective
To determine cutoff values for defining remission, minimal disease activity, and parent and child acceptable symptom state in juvenile idiopathic arthritis (JIA) using the Juvenile Arthritis Disease Activity Score (JADAS).
Methods
For the selection of cutoff values, data from a clinical database including 609 children with JIA were used. Optimal cutoff values were determined against external criteria by calculating the 75th percentile of cumulative score distribution and through receiver operating characteristic curve analysis. External criteria included formal definitions of inactive disease and minimal disease activity, subjective rating of remission by physicians, parents, and children, and rating of acceptable symptom state by parents and children. The choice of cutoffs was made based on clinical and statistical grounds. Cross‐validation was performed using 4 JIA patient samples that included a total of 1,323 patients, and was based on assessment of construct, discriminant, and predictive validity.
Results
With all versions of the JADAS, the cutoff score for classifying a patient as having inactive disease was 1, whereas the cutoff for classification of minimal disease activity was 2 for oligoarticular JIA and 3.8 for polyarticular JIA. Cutoffs for physicians', parents', and children's subjective rating of remission ranged from 2 to 2.3. Cutoffs for acceptable symptom state ranged from 3.2 to 5.4 for parents and from 3 to 4.5 for children. Results of cross‐validation analyses strongly supported the selected cutoff values.
Conclusion
Cutoff values for classifying various disease states in JIA using the JADAS were developed. In cross‐validation analyses, they proved to have good construct and discriminant validity and ability to predict disease outcome.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>22231288</pmid><doi>10.1002/art.34373</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0004-3591 |
ispartof | Arthritis & rheumatology (Hoboken, N.J.), 2012-07, Vol.64 (7), p.2366-2374 |
issn | 0004-3591 2326-5191 1529-0131 2326-5205 |
language | eng |
recordid | cdi_proquest_miscellaneous_1022839874 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Antirheumatic Agents - therapeutic use Arthritis Arthritis, Juvenile - diagnosis Arthritis, Juvenile - drug therapy Arthritis, Juvenile - pathology Biological and medical sciences Child Diseases of the osteoarticular system Female Humans Inflammatory joint diseases Joints - pathology Male Medical research Medical sciences Methotrexate - therapeutic use Parents & parenting Reproducibility of Results Sensitivity and Specificity Severity of Illness Index Surveys and Questionnaires Treatment Outcome |
title | Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T00%3A04%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Remission,%20minimal%20disease%20activity,%20and%20acceptable%20symptom%20state%20in%20juvenile%20idiopathic%20arthritis:%20Defining%20criteria%20based%20on%20the%20juvenile%20arthritis%20disease%20activity%20score&rft.jtitle=Arthritis%20&%20rheumatology%20(Hoboken,%20N.J.)&rft.au=Consolaro,%20Alessandro&rft.aucorp=Paediatric%20Rheumatology%20International%20Trials%20Organization&rft.date=2012-07&rft.volume=64&rft.issue=7&rft.spage=2366&rft.epage=2374&rft.pages=2366-2374&rft.issn=0004-3591&rft.eissn=1529-0131&rft.coden=ARHEAW&rft_id=info:doi/10.1002/art.34373&rft_dat=%3Cproquest_cross%3E3277941431%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1517117661&rft_id=info:pmid/22231288&rfr_iscdi=true |